<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>PRO Alert Digest</title>
  <style>
    body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif; margin: 2rem; color: #222; }
    header { margin-bottom: 2rem; }
    section { margin-bottom: 2rem; background: #f5f5f5; padding: 1rem; border-radius: 0.5rem; }
    section h2 { margin-top: 0; font-size: 1.1rem; color: #333; }
    section ul { margin-bottom: 0; }
    article { margin-bottom: 2rem; }
    article h2 { margin-bottom: 0.5rem; font-size: 1.25rem; }
    article ul { margin-top: 0.5rem; }
    article li b { color: #0066cc; font-weight: bold; }
    .meta { color: #666; font-size: 0.9rem; margin: 0; }
  </style>
</head>
<body>
<header><h1>PRO Alert Digest</h1><p>October 13, 2025</p></header>
<section class="summary">
  <h2>Summary of today's articles</h2>
  <ul>
    <li>67% completion rate achieved with auto-reminders</li>
  </ul>
</section>


<article>
  <h2><a href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1632474/epub">Digital interventions in medication adherence: a narrative review of current evidence and challenges</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 67% completion rate achieved with auto-reminders; reduces discontinuation risk by 30%.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Use push notifications for day-3 reminders to improve patient engagement.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA mandates PRO data in trials within 12 months, increasing urgency for ePRO solutions.</li>
<li><b>CONCERN:</b> Self-selection bias may compromise clinical validity if healthier patients disproportionately complete assessments.</li>
  </ul>
</article>

</body>
</html>
